Adjuvant treatment with pegylated interferon alpha-2a versus low-dose interferon alpha-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial(aEuro)

作者:Eigentler T K; Gutzmer R; Hauschild A; Heinzerling L; Schadendorf D; Nashan D; Hoelzle E; Kiecker F; Becker J; Sunderkoeter C; Moll I; Richtig E; Poenitzsch I; Pehamberger H; Kaufmann R; Pfoehler C; Vogt T; Berking C; Praxmarer M; Garbe C
来源:Annals of Oncology, 2016, 27(8): 1625-1632.
DOI:10.1093/annonc/mdw225